- Home
- ALAR vs VRCA Comparison
ALAR vs VRCA Comparison
Compare ALAR & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALAR
- VRCA
- Stock Information
- Founded
- ALAR 2013
- VRCA 2013
- Country
- ALAR Israel
- VRCA United States
- Employees
- ALAR N/A
- VRCA N/A
- Industry
- ALAR Computer Software: Prepackaged Software
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- ALAR Technology
- VRCA Health Care
- Exchange
- ALAR Nasdaq
- VRCA Nasdaq
- Market Cap
- ALAR 45.3M
- VRCA 54.0M
- IPO Year
- ALAR 2018
- VRCA 2018
- Fundamental
- Price
- ALAR $11.05
- VRCA $0.58
- Analyst Decision
- ALAR Strong Buy
- VRCA Hold
- Analyst Count
- ALAR 1
- VRCA 5
- Target Price
- ALAR $15.00
- VRCA $6.00
- AVG Volume (30 Days)
- ALAR 232.8K
- VRCA 245.7K
- Earning Date
- ALAR 05-29-2025
- VRCA 08-13-2025
- Dividend Yield
- ALAR N/A
- VRCA N/A
- EPS Growth
- ALAR N/A
- VRCA N/A
- EPS
- ALAR 0.07
- VRCA N/A
- Revenue
- ALAR $30,581,000.00
- VRCA $7,179,000.00
- Revenue This Year
- ALAR N/A
- VRCA $171.87
- Revenue Next Year
- ALAR $12.28
- VRCA $71.38
- P/E Ratio
- ALAR $16.75
- VRCA N/A
- Revenue Growth
- ALAR 4.67
- VRCA N/A
- 52 Week Low
- ALAR $5.45
- VRCA $0.38
- 52 Week High
- ALAR $46.69
- VRCA $8.98
- Technical
- Relative Strength Index (RSI)
- ALAR 65.81
- VRCA 49.82
- Support Level
- ALAR $10.43
- VRCA $0.60
- Resistance Level
- ALAR $12.25
- VRCA $0.71
- Average True Range (ATR)
- ALAR 0.83
- VRCA 0.07
- MACD
- ALAR 0.21
- VRCA -0.00
- Stochastic Oscillator
- ALAR 73.26
- VRCA 43.69
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.